Skip to main content

Initiator Pharma A/S (INIT.ST) Stock Price and Company Information, 2024

Sweden / Sverige
First North Sweden Cap (^FNSEEURPI INDEXNASDAQ: FNSEEURPI CAP)

Initiator Pharma A/S

INIT.ST

Exchange: ST
Currency Swedish krone
ISIN: DK0060775872
Fiscal Year End: December
Sector: Healthcare
Industry: Biotechnology
Gic Sector: Health Care
Gic Group: Pharmaceuticals, Biotechnology & Life Sciences
Gic Industry: Biotechnology
Gic Sub Industry: Biotechnology
Description: Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. Its product pipeline includes IPED2015, a drug candidate which is in clinical phase 2a for the treatment of organic erectile dysfunction; IP2018, a monoamine reuptake inhibitor completed Phase I Ia for the treatment of psychogenic erectile dysfunction primarily targeting the serotonin followed by the dopamine system; and IPTN2021, a Phase 1 clinical drug program targeting an orphan drug indication in severe neuropathic pain, and trigeminal neuralgia. The company also developing IP2017, a proprietary triple reuptake inhibitor; and IP2016, a preclinical development for the treatment of depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.
Address: Ole Maaloes vej 3, Copenhagen, Denmark, 2200
Website: https://www.initiatorpharma.com
Full Time Employees: 3
Updated On: 2024-11-05

Highlights

Market Capitalization: 393108800
Market Capitalization Mln: 393.10
EBITDA: -42534752
Wall Street Target Price: 24.32
Book Value: 0.33
Earnings Share: -0.34
Most Recent Quarter: 2024-06-30
Return On Assets TTM: -0.43
Return On Equity TTM: -0.72
Gross Profit TTM: -38425000
Diluted Eps TTM: -0.34

Valuation

Forward PE: 9.81
Price Book MRQ: 13.32
Enterprise Value: 370516127
Enterprise Value Ebitda: -6.17

Technicals

Beta: 0.74
52 Week High: 11.75
52 Week Low: 6.65
50 Day MA: 7.46
200 Day MA: 8.57

Earnings

Report Date: 2025-05-23
Date: 2025-03-31
Before After Market: Before Market
Currency: DKK
Report Date: 2025-02-28
Date: 2024-12-31
Before After Market: After Market
Currency: DKK
Report Date: 2024-11-15
Date: 2024-09-30
Before After Market: After Market
Currency: DKK
Report Date: 2024-08-23
Date: 2024-06-30
Before After Market: Before Market
Currency: DKK
Eps Actual: -0.13
Report Date: 2024-05-10
Date: 2024-03-31
Before After Market: Before Market
Currency: DKK
Eps Actual: -0.11
Report Date: 2024-02-23
Date: 2023-12-31
Before After Market: Before Market
Currency: DKK
Eps Actual: 0.04
Report Date: 2023-11-10
Date: 2023-09-30
Before After Market: Before Market
Currency: DKK
Eps Actual: -0.13
Report Date: 2023-08-25
Date: 2023-06-30
Before After Market: Before Market
Currency: DKK
Eps Actual: -0.30
Report Date: 2023-05-05
Date: 2023-03-31
Before After Market: Before Market
Currency: DKK
Eps Actual: -0.26
Report Date: 2023-02-17
Date: 2022-12-31
Before After Market: Before Market
Currency: DKK
Eps Actual: -0.08
Report Date: 2022-11-04
Date: 2022-09-30
Before After Market: Before Market
Currency: DKK
Eps Actual: -0.16
Report Date: 2022-08-26
Date: 2022-06-30
Before After Market: Before Market
Currency: DKK
Eps Actual: -0.41
Report Date: 2022-05-06
Date: 2022-03-31
Before After Market: Before Market
Currency: DKK
Eps Actual: -0.48
Report Date: 2022-02-18
Date: 2021-12-31
Before After Market: Before Market
Currency: DKK
Eps Actual: -0.43
Date: 2025-12-31
Period: +1y
Growth: -1.00
Earnings Estimate Low: -0.47
Earnings Estimate High: 0.47
Earnings Estimate Year Ago Eps: 1.25
Earnings Estimate Number Of Analysts: 2.00
Earnings Estimate Growth: -1.00
Revenue Estimate Number Of Analysts: 1.00
Revenue Estimate Growth: -0.68
Date: 2024-12-31
Growth: 2.81
Earnings Estimate Year Ago Eps: -0.69
Earnings Estimate Growth: 2.81
Revenue Estimate Avg: 215950000.00
Revenue Estimate Low: 215950000.00
Revenue Estimate High: 215950000.00
Revenue Estimate Number Of Analysts: 1.00
Eps Trend7days Ago: 1.25
Eps Trend30days Ago: 1.25
Eps Trend60days Ago: 1.25
Eps Trend90days Ago: 1.24
Date: 2024-09-30
Period: +1q
Date: 2024-06-30
Date: 2024-03-31
Date: 2023-12-31
Growth: 0.26
Earnings Estimate Avg: -0.82
Earnings Estimate Low: -0.90
Earnings Estimate High: -0.75
Earnings Estimate Year Ago Eps: -1.11
Earnings Estimate Number Of Analysts: 2.00
Earnings Estimate Growth: 0.26
Revenue Estimate Number Of Analysts: 1.00
Eps Trend Current: -0.82
Eps Trend7days Ago: -0.84
Eps Trend30days Ago: -0.85
Eps Trend60days Ago: -0.82
Eps Trend90days Ago: -0.85
Eps Revisions Up Last7days: 1.00
Eps Revisions Up Last30days: 1.00
Date: 2023-09-30
Date: 2023-06-30
Date: 2023-03-31
Date: 2022-12-31
Growth: -0.81
Earnings Estimate Avg: -1.20
Earnings Estimate Low: -1.20
Earnings Estimate High: -1.20
Earnings Estimate Year Ago Eps: -0.66
Earnings Estimate Number Of Analysts: 1.00
Earnings Estimate Growth: -0.81
Revenue Estimate Number Of Analysts: 1.00
Eps Trend Current: -1.20
Eps Trend7days Ago: -1.22
Eps Trend30days Ago: -1.20
Eps Trend60days Ago: -1.19
Eps Trend90days Ago: -1.18
Date: 2022-09-30
Date: 2022-06-30
Date: 2022-03-31
Date: 2024-09-30
Eps Actual: -0.25
Date: 2023-12-31
Eps Actual: -0.66
Date: 2022-12-31
Eps Actual: -1.14
Date: 2021-12-31
Eps Actual: -0.43